Streptococcus Equi Antibody, Equine Origin*

the first and only USDA licensed product  for treatment after the onset of symptoms

Mg Biologics is now making available the first and only USDA licensed* product for passive immunity in clinically ill horses with Streptococcus equi after the onset of disease.

Streptococcus Equi Antibody is intended for use in horses as an aid in the control of diseases associated with Steptococcus equi infection.  Approximately 200 ml per 100 pounds body weight shall be administered intravenously at any age of life. Research has show the administration of Streptococcus equi antibodies can reduce the mortality, duration, and severity of the disease after the clinical signs of disease have been observed.

Mg Biologics maintains a quarantined herd of donors that have been tested for antibodies against Aa, Ca and Qa red cell antibodies. All Streptococcus Equi Antibody is produced with state of the art equipment, experienced technicians and processes to preclude potential contamination. All Streptococcus Equi Antibody is intended for IV use in equine of all ages.

Mg Biologics seeks to offer the industry what they want in their IV products: fast thawing time (5-10 minutes) and fast administration time (average time of 7 minutes per liter on 100 foals at our farm).

The time of administration is related to the quality of the production process, not "plasma" in general. Mg Biologics also provides a thinner plasma bag. This is unique in the industry and reduces thaw time to only 10 minutes. Now veterinarians can take plasma from the freezer and be finished with the dosing in less than 20 minutes!

*conditionally licensed